Syros Pharmaceuticals, Inc.

NasdaqGS:SYRS Stock Report

Market Cap: US$155.0m

Syros Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:SYRS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Dec 23BuyUS$3,999,998Samsara BioCapital LLCCompany904,977US$4.42

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SYRS?
Owner TypeNumber of SharesOwnership Percentage
Private Companies950.000355%
Individual Insiders438,2181.64%
General Public3,974,59214.9%
Hedge Funds5,217,22319.5%
VC/PE Firms8,534,50031.9%
Institutions8,563,70932%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.8%.


Top Shareholders

Top 25 shareholders own 78.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
Bain Capital Life Sciences Investors, LLC
2,749,808US$15.9m0%1.62%
9.37%
Artal Group S.A.
2,505,013US$14.5m0%0.34%
7.75%
Adage Capital Management, L.P.
2,071,914US$12.0m0%0.02%
6.68%
Samsara BioCapital LLC
1,786,427US$10.4m0%2.31%
6.26%
Avidity Partners Management, L.P.
1,673,538US$9.7m0%0.38%
5.59%
CHI Advisors LLC
1,493,252US$8.7m338%3.09%
5.51%
Point72 Asset Management, L.P.
1,471,771US$8.5m0%0.02%
4.84%
Flagship Pioneering, Inc
1,293,849US$7.5m0%0.76%
3.47%
The Vanguard Group, Inc.
928,046US$5.4m21.3%no data
2.95%
Opaleye Management Inc.
787,545US$4.6m119%1.08%
1.99%
Cowen Inc,Private Banking and Investment Banking Investments
531,914US$3.1m0%0.09%
1.98%
Medical Strategy GmbH, Asset Management Arm
528,190US$3.1m0%0.17%
1.67%
Goldman Sachs Group, Investment Banking and Securities Investments
446,591US$2.6m86.3%no data
1.51%
Kennedy Capital Management LLC
404,914US$2.3m0%0.05%
1.07%
Walleye Capital LLC
284,936US$1.7m0%0.01%
0.98%
Millennium Management LLC
261,083US$1.5m0%no data
0.96%
BlackRock, Inc.
257,041US$1.5m4.09%no data
0.94%
Omega Fund Management, LLC
251,270US$1.5m0%0.94%
0.87%
Knott Partners Management, LLC
233,000US$1.4m192%0.45%
0.82%
Geode Capital Management, LLC
220,245US$1.3m36.3%no data
0.65%
UBS O'Connor LLC
175,000US$1.0m34.6%0.09%
0.65%
Jane Street Group, LLC, Asset Management Arm
172,517US$1.0m716%no data
0.64%
Assenagon Asset Management S.A.
169,999US$986.0k576%no data
0.6%
Marshall Wace LLP
159,584US$925.6k543%no data
0.58%
ExodusPoint Capital Management, LP
154,989US$898.9k49.7%0.01%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.